Timber Pharmaceuticals Inc TMBR:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
1.25quote price arrow up+0.01 (+0.81%)
Volume
131,659
Close
1.24quote price arrow up+0.08 (+6.90%)
Volume
2,263,806
52 week range
0.67 - 3.65

...

Loading . . .
  • Open1.13
  • Day High1.24
  • Day Low1.13
  • Prev Close1.16
  • 52 Week High3.65
  • 52 Week High Date03/11/21
  • 52 Week Low0.67
  • 52 Week Low Date12/22/20

Key Stats

  • Market Cap45.68M
  • Shares Out36.84M
  • 10 Day Average Volume1.60M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change66.89

KEY STATS

  • Open1.13
  • Day High1.24
  • Day Low1.13
  • Prev Close1.16
  • 52 Week High3.65
  • 52 Week High Date03/11/21
  • 52 Week Low0.67
  • 52 Week Low Date12/22/20
  • Market Cap45.68M
  • Shares Out36.84M
  • 10 Day Average Volume1.60M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change66.89

RATIOS/PROFITABILITY

  • EPS (TTM)-1.24
  • P/E (TTM)-1.00
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-19.137M
  • ROE (MRQ)-702.42%
  • Revenue (MRQ)470,000.00
  • Gross Margin (MRQ)0.00%
  • Net Margin (MRQ)-2,881.18%
  • Debt To Equity (MRQ)0.49%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Timber Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Timber Pharmaceuticals, Inc., formerly BioPharmX Corporation, is a biopharmaceutical company. The Company is focused on the development and commercialization of treatments for orphan dermatologic diseases. It is developing treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its pipeline includes TMB-001, TMB-002 and TMB-003. TMB-001 is a topical isotretinoin, which is being developed for...
John Koconis
Chief Executive Officer
Zachary Rome
Chief Operating Officer
Joseph Lucchese
Chief Financial Officer
Joyce Goto
Chief Accounting Officer
Address
110 ALLEN ROAD, SUITE 401
Basking Ridge, NJ
07920
United States

Top Peers

SYMBOLLASTCHG%CHG
EVOK
Evoke Pharma Inc
1.42+0.01+0.71%
BXRX
Baudax Bio Inc
0.813+0.0429+5.57%
NAVB
Navidea Biopharmaceuticals Inc
1.95+0.04+2.09%
ACUR
Acura Pharmaceuticals Inc
0.67+0.07+11.67%
AGRX
Agile Therapeutics Inc
1.40UNCHUNCH
SCPH
scPharmaceuticals Inc
5.45-0.03-0.55%